The Challenging World of Cytopenias: Distinguishing Myelodysplastic Syndromes From Other Disorders of Marrow Failure
|
Jun 2014
|
Oncologist
|
myelodysplastic syndromes (MDS)
|
The Challenge of Treating Myelodysplastic Syndromes/Myeloproliferative Neoplasms.
|
Jul 2017
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes
|
Jan 2019
|
Blood
|
myelodysplastic syndromes (MDS)
|
The case for upfront HLA-matched unrelated donor HCT as a curative option for adult acquired severe aplastic anemia: Upfront MUD HCT for adult severe aplastic anemia
|
May 2019
|
Biology of Blood and Marrow Transplantation: Journal of the American Society of Blood and Marrow Transplantation
|
aplastic anemia
|
Telomere length in hematopoietic stem cell transplantation for severe aplastic anemia: is it ready for "prime time"?
|
Feb 2015
|
JAMA
|
aplastic anemia
|
Telomere length in hematopoietic stem cell transplantation for severe aplastic anemia: is it ready for "prime time"?
|
Feb 2015
|
JAMA
|
aplastic anemia
|
Telomerase, hTERT and splice variants in patients with myelodysplastic syndromes
|
Apr 2014
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Tea consumption reduces the risk of de novo myelodysplastic syndromes
|
Dec 2014
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Targeting TP53 Mutations in Myelodysplastic Syndromes
|
Apr 2020
|
Hematology/oncology clinics of North America
|
myelodysplastic syndromes (MDS)
|
Targeting the Microenvironment in MDS: The Final Frontier
|
Jul 2020
|
Frontiers in Pharmacology
|
myelodysplastic syndromes (MDS)
|